ISRCTN10939948
Completed
未知
Treatment of Clinically Significative diabetic Macular Edema: influence of Bevacizumab, Triamcinolone and the combination of both plus macular grid thermal laser Photocoagulation of subthreshold
Opthalmological Foundation of the Mediterranean (Fundacion Oftalmologica del Mediterraneo) (Spain)0 sites60 target enrollmentMay 15, 2007
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Opthalmological Foundation of the Mediterranean (Fundacion Oftalmologica del Mediterraneo) (Spain)
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Diabetic CSME not treated previously
- •2\. Best Corrected Visual Acuity (BCVA) less than 20/40
- •3\. Patient able to complete follow\-up
- •4\. Controlled diabetes
Exclusion Criteria
- •1\. Other associated ocular pathology
- •2\. Ocular surgery three months before the inclusion
- •3\. Participating in other interventional studies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Optimised treatment for pre-existing diabetic macular oedema during cataract surgeryDiabetic Macular Oedema in type 2 diabetic patients with visually significant cataractEar, Nose and ThroatCataract, diabetic macular oedema, type 2 diabetes mellitus with ophthalmic complicationsISRCTN18293240Chinese University of Hong Kong92
Active, not recruiting
Phase 1
Investigation of Eylea for patients with diabetic macular edema in an outpatient Setting.Diabetic Retinopathy and diabetic macular edema are leading causes for visual loss and blindness in young adults around the world.MedDRA version: 18.0Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2015-000959-24-ATAbteilung für Augenheilkunde, AKH Linz50
Recruiting
Phase 2
Assessment of medical treatment of diabetes on comorbid diastolic let-ventricular dysfunction observed by cardiac MRI in diabetic patientsHeart failure with diastolic dysfunction and comorbid diabetes.JPRN-UMIN000012209Cardiology, Nagoya University50
Active, not recruiting
Not Applicable
The Most Effective Treatment Strategy for Diabetic Macular Edema.diabetic macular edemaMedDRA version: 15.0Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2012-003652-36-NLThe Rotterdam Eye Hospital
Completed
Not Applicable
The Most Effective Treatment Strategy for Diabetic Macular Edema.diabetic macular edema1001265310015917NL-OMON39983Oogziekenhuis Rotterdam456